| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
11,411 |
9,237 |
$849K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,260 |
10,365 |
$580K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,428 |
2,771 |
$257K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,108 |
2,718 |
$255K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,222 |
2,910 |
$241K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,378 |
2,034 |
$161K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
7,151 |
6,139 |
$86K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
556 |
444 |
$79K |
| 96127 |
|
3,886 |
3,430 |
$60K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
3,024 |
2,536 |
$48K |
| 90686 |
|
4,954 |
4,422 |
$45K |
| 90651 |
|
1,766 |
1,489 |
$42K |
| D1206 |
Topical application of fluoride varnish |
1,432 |
1,382 |
$37K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
845 |
634 |
$30K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,141 |
1,061 |
$27K |
| 90734 |
|
1,442 |
1,264 |
$25K |
| 90670 |
|
2,334 |
2,042 |
$25K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,367 |
701 |
$24K |
| 90698 |
|
2,412 |
2,081 |
$23K |
| 83655 |
|
1,645 |
1,374 |
$19K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,192 |
1,035 |
$18K |
| 99383 |
|
195 |
179 |
$18K |
| 90633 |
|
1,458 |
1,274 |
$13K |
| 90715 |
|
1,069 |
869 |
$13K |
| 90674 |
|
746 |
633 |
$12K |
| 90620 |
|
781 |
650 |
$11K |
| 90619 |
|
667 |
480 |
$11K |
| 90744 |
|
1,289 |
1,099 |
$11K |
| 99402 |
|
388 |
228 |
$10K |
| 90680 |
|
1,308 |
1,155 |
$10K |
| 90716 |
|
704 |
627 |
$10K |
| 96160 |
|
643 |
494 |
$9K |
| 90661 |
|
452 |
435 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
291 |
262 |
$7K |
| 90707 |
|
604 |
536 |
$7K |
| 92551 |
|
430 |
357 |
$7K |
| 0071A |
|
152 |
104 |
$6K |
| 85018 |
|
2,546 |
2,162 |
$6K |
| 90671 |
|
280 |
208 |
$5K |
| 90710 |
|
456 |
343 |
$5K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
62 |
49 |
$5K |
| 36416 |
|
1,239 |
1,076 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
89 |
53 |
$5K |
| 90700 |
|
375 |
303 |
$4K |
| 90696 |
|
448 |
349 |
$4K |
| 99384 |
|
37 |
33 |
$4K |
| 99382 |
|
39 |
33 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
234 |
118 |
$3K |
| 90713 |
|
251 |
212 |
$3K |
| 0072A |
|
67 |
50 |
$3K |
| 99174 |
|
372 |
292 |
$3K |
| 83718 |
|
337 |
284 |
$3K |
| 91321 |
|
77 |
70 |
$2K |
| 92015 |
Determination of refractive state |
109 |
94 |
$2K |
| 0001A |
|
42 |
42 |
$2K |
| 90656 |
|
104 |
104 |
$2K |
| 81002 |
|
637 |
531 |
$2K |
| 0002A |
|
39 |
39 |
$2K |
| 90647 |
|
133 |
114 |
$2K |
| 99381 |
|
18 |
16 |
$2K |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
100 |
83 |
$1K |
| 82465 |
|
343 |
297 |
$1K |
| 99173 |
|
172 |
121 |
$1K |
| 0111A |
|
14 |
14 |
$585.20 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
12 |
12 |
$489.94 |
| 82947 |
|
108 |
78 |
$389.64 |
| 99422 |
|
14 |
12 |
$379.96 |
| 94761 |
|
49 |
41 |
$349.60 |
| A4606 |
Oxygen probe for use with oximeter device, replacement |
72 |
42 |
$173.69 |
| 90685 |
|
17 |
14 |
$166.00 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
12 |
12 |
$117.72 |
| 94760 |
|
45 |
39 |
$66.00 |
| G0438 |
Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit |
63 |
55 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
18 |
18 |
$0.00 |